Winton Group’s GenMark Diagnostics, Inc GNMK Stock Holding History

Winton Group’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-28,199	Closed	-$674K	–	1561
2021 Q1	$674K	Buy	28,199 +11,607	+70%	+$216K	0.04%	711
2020 Q4	$242K	Buy	+16,592	New	+$220K	0.02%	1126

Winton Group's GNMK Position: Q2 2021 in Review

Winton Group sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 28,199 shares — an estimated $674K sold.

Winton Group first reported a position in GNMK in Q4 2020 and held it in 2 quarters. The position peaked at $674K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Winton Group reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Winton Group sold 28,199 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $674K.
Winton Group first reported a position in GenMark Diagnostics, Inc in Q4 2020 and held it in 2 quarters.
Winton Group's GenMark Diagnostics, Inc position peaked at $674K in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Winton Group's 13F filing for Q2 2021, filed 10 Aug 2021.